Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells

Annals of Allergy, Asthma and Immunology

Volumn 79, Issue 6, 1997, Pages 541-545

  Yanni, John M ^a   Miller, Steven T ^a   Gamache, Daniel A ^a   Spellman, Joan M ^a   Xu, Shouxi ^a   Sharif, Najam A ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; HISTAMINE; HISTAMINE H1 RECEPTOR; IMMUNOGLOBULIN E ANTIBODY; NEDOCROMIL; OLOPATADINE; PEMIROLAST; RECEPTOR SUBTYPE;

ALLERGIC CONJUNCTIVITIS; ARTICLE; CONCENTRATION RESPONSE; CONJUNCTIVA; DRUG RECEPTOR BINDING; HISTAMINE RELEASE; HUMAN; HUMAN CELL; LIGAND BINDING; MAST CELL; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0031449146     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63063-3     Document Type: Article

References (35)

1. Massicot, JG, Cohen SG. Epidemiologic and socioeconomic aspects of allergic diseases. J Allergy Clin Immunol 1986;78:954-8.
2. Kaliner M, Eggleston PA, Mathews KP. Rhinitis and asthma. JAMA 1987;258:2851-73.
3. Friedlaender MH. Current concepts in ocular allergy. Ann Allergy 1991;67: 5-13.
4. Abelson M, Allansmith M, Friedlander M. Effects of topically applied ocular decongestant and antihistamine. Am J Ophthalmol 1980;90:254-7.
5. Abelson M, Schaefer K. Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapy. Surv Ophthalmol 1993;38(Suppl):115-32.
6. Orr TSC, Hall DE, Gwilliam DM, Cox JSG. The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48/80. Life Sci 1971;10: 805-12.
7. Kusner EJ, Dubnick B, Herzig DJ. The inhibition by disodium cromoglycate in vitro of anaphylactically induced histamine release from rat peritoneal mast cells. J Pharmacol Exp Ther 1973;184:41-6.
8. Azevedo M, Castel-Branco MG, Oliveira JF, et al. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 1991;21: 689-94.
9. Rimas M, Kjellman NI, Blychert LO, Bjorksten B. Topical levocabastine protects better than sodium cromoglycate and placebo in conjunctival provocation tests. Allergy 1990;45:18-21.
10. Stock EL, Bielory L. Treatment of ocular allergy. Immunol Allergy Clin N Am 1997;17:75-87.
11. Broide D, Marquardt D, Wasserman S. Effect of nedocromil sodium and sodium cromoglycate on connective tissue and bone marrow derived mast cells: acute and chronic studies. Eur J Respir Dis 1986;60(Suppl 147): 196-8.
12. 2 release from primate bronchoalveolar mast cells and a comparison with rat peritoneal mast cells. J Immunol 1986;127: 3941-5.
13. Sasaki Y, Ikeda Y, Ikemura T, et al. Effect of the new antiallergic drug KW-4679 on histamine and leukotriene released by the abdominal cavity effusion cells in rats. Clin Pharmacol Ther 1995;5:1837-50.
14. Yanagihara Y, Kasai H, Shida T. Immunopharmacological studies on TBX, a new antiallergic drug (2). Inhibitory effects on histamine release from peritoneal mast cells and lung fragments of rats. Jpn J Pharmacol 1988;48:103-12.
15. Lowman MA, Rees PH, Benyon RC, Church MK, Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988;81:590-7.
16. Irani AMA, Schwartz LB. Mast cell heterogeneity. Clin Exp Allergy 1989; 19:143-55.
17. Lawrence ID, Warner JA, Cohan VL, et al. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity. J Immunol 1987;139:3062-9.
18. Miller S, Cook E, Graziano F, et al. Human conjunctival mast cell responses in vitro to various secretagogues. Ocular Immunol Inflamm 1996;4:39-49.
19. 1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies. J Ocular Pharmacol 1994;10:653-64.
20. Calonge M, Montero JA, Herreras JM, et al. Efficacy of nedocromil sodium and cromolyn sodium in an experimental model of ocular allergy. Ann Allergy Asthma Immunol 1996;77:124-30.
21. Yanagihara Y, Kasai H, Kawashima T, Shida T. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs. Jpn J Pharmacol 1988;48:91-101.
22. Beauvais F, Hieblot C, Benveniste J. Effect of sodium cromoglycate and nedocromil sodium on anti-IgE-induced and anti-IgG4-induced basophil degranulation. Drugs 1989;37(Suppl 1):4-8.
23. Church MK, Holgate ST, Pao GJK. Histamine release from mechanically and enzymatically dispersed human lung mast cells: inhibition by salbutamol and cromoglycate. [Abstract]. Br J Pharmacol 1983;79(Suppl):374P.
24. Fox CC, Wolf EJ, Kagey-Sabotka A, Lichtenstein LM. Comparison of human lung and intestinal mast cells. J Allergy Clin Immunol 1988;81:89-94.
25. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992;97:216-25.
26. Okayama Y, Benyon RC, Rees PH et al. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, tonsil, adenoid and intestine. Clin Exp Allergy 1992;22:401-9.
27. Thomson DS, Evans DP. Inhibition of immediate hypersensitivity reactions by disodium cromoglycate: requirements for activity in two laboratory animals. Clin Exp Immunol 1973;13: 537-44.
28. Johnson HG, Van Hout CA. The enhanced efficacy of disodium cromoglycate (DSCG) in DSCG predosed rats. Proc Soc Exp Biol Med 1973;143: 427-9.
29. Yanni JM, Stephens DJ, Miller ST, et al. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/ antihistaminic agent. J Ocular Pharmacol Ther 1996;12:389-400.
30. Sharif NA, Xu SX, Miller ST, et al. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 1996;278: 1252-61.
31. Berdy G, Abelson M, George M, et al. Allergic conjunctivitis: a survey of new antihistamines. J Ocular Pharmacol 1991;7:313-24.
32. Woodward DF, Ledgard SE, Nieves AL. Conjunctival immediate hypersensitivity: reevaluation of histamine involvement in the vasopermeability response. Invest Ophthalmol Vis Sci 1986;27:57-63.
33. Cox JSG. Disodium cromoglycate, FPL670 (Intal). A specific inhibitor of reaginic antibody/antigen mechanisms. Nature 1967;216:1328-9.
34. Humphreys F, Shuster S. The effect of nedocromil on weal reactions in human skin. Br J Clin Pharmacol 1987;24:405-8.
35. 1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis. J Ocular Pharmacol Ther 1996;12:401-7.